463 Vibostolimab plus pembrolizumab with/without docetaxel vs docetaxel in NSCLC after platinum chemotherapy and immunotherapy
oleh: Dae Ho Lee, Silvia Novello, Solange Peters, Balazs Halmos, David Planchard, Rodryg Ramlau, Christian Schumann, Niyati Bhagwati, Diana (Qiusheng) Chen, Debra Kush
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.